Preferred Label : Immune-Modified Response Evaluation Criteria in Solid Tumors;
NCIt related terms : Immune-Modified Response Evaluation Criteria in Solid Tumors (iRECIST); iRECIST;
NCIt definition : A modification of the Response Evaluation Criteria in Solid Tumors (RECIST), version
1.1, for use as a standard approach to solid tumor measurements and definitions for
objective change in tumor size in cancer clinical trials in which an immunotherapy
is used.;
Alternative definition : CDISC: iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics.
(Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, Mandrekar S, Lin NU, Litiere
S, Dancey J, Chen A, Hodi FS, Therasse P, Hoekstra OS, Shankar LK, Wolchok JD, Ballinger
M, Caramella C, de Vries EG; RECIST working group. iRECIST: guidelines for response
criteria for use in trials testing immunotherapeutics. Lancet Oncol. 2017 Mar;18(3):e143-e152.);
NCI Metathesaurus CUI : CL524515;
Origin ID : C136711;
UMLS CUI : C4526911;
Semantic type(s)
- concept_is_in_subset
